Intensive Care Utilization in Stable Patients With ST-Segment Elevation Myocardial Infarction Treated With Rapid Reperfusion

被引:38
|
作者
Shavadia, Jay S. [1 ,2 ]
Chen, Anita Y. [1 ]
Fanaroff, Alexander C. [1 ]
de Lemos, James A. [3 ]
Kontos, Michael C. [4 ]
Wang, Tracy Y. [1 ]
机构
[1] Duke Clin Res Inst, 2400 Pratt St,Room 7035, Durham, NC 27705 USA
[2] Univ Saskatchewan, Dept Med, Div Cardiol, Saskatoon, SK, Canada
[3] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA
[4] Virginia Commonwealth Univ, Pauley Heart Ctr, Richmond, VA USA
关键词
intensive care unit; ST-segment elevation myocardial infarction; uncomplicated; utilization; CORONARY-CARE; PRIMARY PCI; UNIT; TRENDS; MANAGEMENT; MORTALITY; EVOLUTION; OUTCOMES;
D O I
10.1016/j.jcin.2019.01.230
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aims of this study were to describe variability in intensive care unit (ICU) utilization for patients with uncomplicated ST-segment elevation myocardial infarction (STEMI), evaluate the proportion of these patients who developed in-hospital complications requiring ICU care, and assess whether ICU use patterns and complication rates vary across categories of first medical contact to device times. BACKGROUND In the era of rapid primary percutaneous coronary intervention, ICUs may be overutilized as patients presenting with STEMI are less likely to develop complications requiring ICU care. METHODS Using data from the Chest Pain-MI Registry linked to Medicare claims, the authors examined patterns of ICU utilization among hemodynamically stable patients with STEMI >= 65 years of age treated with uncomplicated primary percutaneous coronary intervention, stratified by timing of reperfusion: early (first medical contact-to-device time <= 60 min), intermediate (61 to 90 min), or late (>90 min). RESULTS Of 19,507 patients with STEMI treated at 707 hospitals, 82.3% were treated in ICUs, with a median ICU stay of 1 day (interquartile range [IQR]: 1 to 2 days). The median FMC-to-device time was 79 min (IQR: 63 to 99 min); 22.0% of patients had early, 44.8% intermediate, and 33.2% late reperfusion. ICU utilization rates did not differ between patients with early, intermediate, and late reperfusion times (82%, 83%, and 82%; p for trend = 0.44). Overall, 3,159 patients (16.2%) developed complications requiring ICU care while hospitalized: 3.7% died, 3.7% had cardiac arrest, 8.7% shock, 0.9% stroke, 4.1% high-grade atrioventricular block requiring treatment, and 5.7% respiratory failure. Patients with longer FMC-to-device times were more likely to develop at least 1 of these complications (early 13.4%, intermediate 15.7%, and late 18.7%; p for trend < 0.001; adjusted odds ratio [early as reference] for intermediate: 1.13 [95% confidence interval: 1.01 to 1.25]; adjusted odds ratio for late: 1.22 [95% confidence interval: 1.08 to 1.37]). CONCLUSIONS Although >80% of stable patients with STEMI are treated in the ICU after primary percutaneous coronary intervention, the risk for developing a complication requiring ICU care is 16%. Implementing a risk-based triage strategy, inclusive of factors such as degree of reperfusion delay, could optimize ICU utilization for patients with STEMI. (C) 2019 by the American College of Cardiology Foundation.
引用
收藏
页码:709 / 717
页数:9
相关论文
共 50 条
  • [21] ST-segment elevation myocardial infarction
    Yerem Yeghiazarians
    Peter H. Stone
    Current Treatment Options in Cardiovascular Medicine, 2002, 4 (1) : 3 - 23
  • [22] ST-segment elevation myocardial infarction
    Birgit Vogel
    Bimmer E. Claessen
    Suzanne V. Arnold
    Danny Chan
    David J. Cohen
    Evangelos Giannitsis
    C. Michael Gibson
    Shinya Goto
    Hugo A. Katus
    Mathieu Kerneis
    Takeshi Kimura
    Vijay Kunadian
    Duane S. Pinto
    Hiroki Shiomi
    John A. Spertus
    P. Gabriel Steg
    Roxana Mehran
    Nature Reviews Disease Primers, 5
  • [23] Fondaparinux in patients with ST-segment elevation myocardial infarction
    Hartig, Frank
    Eller, Philipp
    Pechlaner, Christoph
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (17): : 2087 - 2087
  • [24] ST-Segment Elevation Myocardial Infarction
    Younis, George A.
    TEXAS HEART INSTITUTE JOURNAL, 2022, 49 (05) : 111 - 111
  • [25] ST-segment elevation myocardial infarction
    Vogel, Birgit
    Claessen, Bimmer E.
    Arnold, Suzanne, V
    Chan, Danny
    Cohen, David J.
    Giannitsis, Evangelos
    Gibson, C. Michael
    Coto, Shinya
    Katus, Hugo A.
    Kerneis, Mathieu
    Kimura, Takeshi
    Kunadian, Vijay
    Pinto, Duane S.
    Shiomi, Hiroki
    Spertus, John A.
    Steg, P. Gabriel
    Mehran, Roxana
    NATURE REVIEWS DISEASE PRIMERS, 2019, 5 (1)
  • [27] Bivalirudin in patients with ST-segment elevation myocardial infarction
    Coughlan, J. J.
    Kastrati, Adnan
    LANCET, 2022, 400 (10366): : 1822 - 1823
  • [28] ST-resolution and spontaneous reperfusion in patients with transient ST-segment elevation myocardial infarction
    Lemkes, Jorrit S.
    Janssens, Gladys N.
    van Royen, Niels
    EUROPEAN HEART JOURNAL, 2019, 40 (29) : 2465 - 2465
  • [29] Analysis of the TIMI score in patients admitted with ST-segment elevation myocardial infarction in an intensive care unit
    SLM Arruda
    HJP Branisso
    EC Figueiredo
    VA Pereira
    JA Luna
    TPF Araujo
    Critical Care, 11 (Suppl 3):
  • [30] BivalirudinIn Patients with ST-Segment Elevation Myocardial Infarction
    Monique P. Curran
    Drugs, 2010, 70 : 909 - 918